- Home
- » Tags
- » Dengue vaccine
Top View
- Developing Nations Struggle to Obtain Sufficient Vaccines UN Security Council Calls for Improved Access Agence France-Presse Recent Surveys Have Shown Pa Newspaper
- Dengue Vaccine Development: Status and Future
- Dengue Vaccine Evidence to Recommendations Framework
- A Deferred-Vaccination Design to Assess Durability of COVID-19
- Dengue and Dengue Vaccines
- Tetravalent Dengue Vaccine
- Dengvaxia, Common Name
- Ad-Hoc Virtual TAG Meeting 2016
- Clinical Study Report
- Guidelines on the Quality, Safety and Efficacy of Dengue Tetravalent Vaccines (Live, Attenuated) Replacement of Annex 1 of WHO Technical Report Series, No
- Takeda in Vaccines
- Clinical Study Report
- Statistical Analysis Plan (SAP) - Core Body Part
- Global Advisory Committee on Vaccine Safety (GACVS)
- Centers for Disease Control and Prevention Immunization Safety Office Update
- Accelerating Availability of Vaccine Candidates for COVID-19
- Takeda Vaccines Innovation for Global Impact
- Advisory Committee on Immunization Practices (ACIP) Meeting Minutes, October 2019
- COVID-19 Vaccine Deployment: Behaviour, Ethics, Misinformation
- COVID-19, Chikungunya, Dengue and Zika Diseases
- Immunological Mechanisms of Vaccine-Induced Protection Against COVID-19 in Humans
- The Distribution of COVID-19 Vaccines
- Implementation of Dengue Vaccine in Puerto Rico Dr
- June 2021 CDC Update
- Progress Toward Implementation of Human Papillomavirus Vaccination
- Novel Safety Issues and Areas That Require Further Research
- Vaccine-Preventable Diseases and Vaccines
- View Article
- Immunogenicity and Safety of a Tetravalent Dengue
- Dengue Vaccine: WHO Position Paper – July 2016
- When Can One Vaccinate with a Live Vaccine After Wild-Type Dengue Infection?
- Covid-19 Vaccines.Pdf
- Vaccine Development for Emerging Infectious Diseases
- Information Update on Dengue Vaccine
- Safety and Immunogenicity of a Dengue Virus Serotype-1 Purified-Inactivated Vaccine: Results of a Phase 1 Clinical Trial
- A Review on Dengue Vaccine Development
- Novel Vaccine Safety Issues and Areas That Would Benefit from Further Research
- Covid-19 Vaccine Development: Building on a Legacy of Innovation
- Vaccines: Myths and Reality Historical Perspective: What Do We Know So Far on Vaccines Causing AEFI?
- Immunization: Vital Progress, Unfinished Agenda
- Real-Time Learning Network Vaccines FAQ Last Reviewed: August 24, 2021
- 18 June 2021 Agenda Item 7 Attachment A
- Dengue Management and Prevention in Vietnam, Indonesia And
- Development of Safe and Effective COVID-19 Vaccines
- An Overview of Vaccines Against SARS-Cov-2 in the COVID-19 Pandemic Era
- Dengue Vaccines: Current Status and Future Prospects
- Early Efficacy from Covid-19 Phase 3 Vaccine Studies: Ethical, Operational, & Scientific Considerations
- Novel Safety Issues and Areas That Require Further Research Situation Paper
- Worse Than the Disease? Reviewing Some Possible Unintended Consequences of the Mrna Vaccines Against COVID-19
- Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned About Enhanced Disease After Vaccination? There Is Only One True Winner